Treatment Effectiveness
User reported effectiveness ratings Codeine for various conditions.
| Conditions | Major Improvement | Moderate Improvement | Much Worse | No Effect | Worse | Responses |
|---|---|---|---|---|---|---|
| Fibromyalgia | 9% | 48% | 7% | 30% | 6% | 150 |
| Lower Back Pain | 9% | 55% | 2% | 35% | 0% | 55 |
| Osteoarthritis | 25% | 0% | 0% | 75% | 0% | 4 |
| Peripheral Neuropathy | 0% | 33% | 22% | 11% | 33% | 9 |
| Premenstrual Syndrome (PMS) | 0% | 100% | 0% | 0% | 0% | 1 |
| Restless Legs Syndrome | 24% | 52% | 0% | 24% | 0% | 21 |
| Vulvar Vestibulitis | 25% | 0% | 0% | 75% | 0% | 4 |
| Insomnia | 6% | 40% | 8% | 30% | 16% | 77 |
Side Effects
User-reported side effects of Codeine
| Side Effect | Percent of Reports Codeine |
|---|---|
| Constipation | 46% |
| Stomach Pain | 27% |
| Convex Spots on Lower Arms | 0% |
| Difficulty Urinating | 7% |
| Dizziness | 33% |
| Drowsiness | 50% |
| Increase Blood Sugars (Diabetes) | 5% |
| Lightheadedness | 39% |
| Mood Changes | 22% |
| Muscle Fatigue | 19% |
| Muscle Spasms | 16% |
| Thick Feat | 5% |
| Vomiting | 7% |
| Headache | 22% |
| Nausea | 26% |
Outcomes
Below is the degree of change seen after Codeine is higher than average.
|
|
Outcomes Label
Codeine Info
| Property | Value |
|---|---|
| Variable Name | Codeine |
| Aggregation Method | SUM |
| Analysis Performed At | 2020-03-25 |
| Duration of Action | 21 days |
| Filling Value | 0 |
| Minimum Allowed Value | 0 count |
| Number of Aggregate Predictors | 0 |
| Number of Aggregate Outcomes | 0 |
| Number of Measurements | 0 |
| Number of Measurements (including those generated by tagged, joined, or child variables) | 0 |
| Public | true |
| Onset Delay | 30 minutes |
| Unit | Count |
| User Variables | 0 |
| Variable Category | Treatments |
| Variable ID | 92970 |